Balaxi Pharmaceuticals Complete Financial Statements
BALAXI • Review detailed financials to uncover trends, confirm thesis & journal trades
7 Years of Data
2025 - 2019
Complete Financial Data Export
Export complete financial statements for Balaxi Pharmaceuticals (BALAXI).
Downloads include all available records across all periods.
For market performance, see the
BALAXI stock price today
.
Profitability Ratios
EBITDA Margin
5.17%
2025 data
Operating Margin
2.00%
2025 data
Balance Sheet Ratios
Current Ratio
10.13
2025 data
Debt to Equity
1.34
2025 data
Equity Ratio
74.84%
2025 data
Asset Turnover
0.19
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
-20.5%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-57.1%
Year-over-Year
Expense Growth
-17.9%
Year-over-Year
Assets Growth
+20.2%
Year-over-Year
Equity Growth
+15.4%
Year-over-Year
Liabilities Growth
+20.2%
Year-over-Year
Operating Cash Flow Growth
-800.0%
Year-over-Year
Investing Cash Flow Growth
-2100.0%
Year-over-Year
Financing Cash Flow Growth
+13.3%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 58 | 75 | 69 | 73 | 59 | 64 | 77 | 61 | 81 | 65 | 62 | 91 | 93 | 86 | 82 | 70 | 53 | 60 | 61 | 62 | 12 | 54 | 66 | 13 | 7 | 8 | 14 |
| Expenses | 55 | 64 | 67 | 67 | 46 | 56 | 69 | 44 | 68 | 104 | 47 | 72 | 78 | 69 | 71 | 56 | 43 | 47 | 48 | 50 | 10 | 43 | 54 | 12 | 5 | 7 | 10 |
| EBITDA | 3 | 11 | 2 | 7 | 13 | 8 | 8 | 17 | 13 | -39 | 15 | 19 | 15 | 17 | 11 | 14 | 10 | 13 | 13 | 12 | 2 | 11 | 12 | 2 | 1 | 1 | 4 |
| Operating Profit Margin % | 2.00% | 16.00% | 6.00% | 14.00% | 23.00% | 15.00% | 5.00% | 20.00% | 16.00% | -57.00% | 22.00% | 17.00% | 13.00% | 17.00% | 18.00% | 20.00% | 19.00% | 20.00% | 22.00% | 17.00% | 15.00% | 17.00% | 18.00% | 8.00% | 11.00% | 18.00% | 21.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 10 | 1 | 6 | 12 | 7 | 6 | 16 | 11 | -39 | 14 | 19 | 15 | 17 | 11 | 14 | 10 | 13 | 13 | 12 | 2 | 11 | 12 | 2 | 1 | 1 | 4 |
| Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 2 | 1 | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 2 | 1 | 0 | 1 | 0 | 1 |
| Net Profit | 0 | 9 | 0 | 5 | 11 | 7 | 5 | 14 | 8 | -41 | 14 | 16 | 13 | 14 | 8 | 12 | 8 | 11 | 12 | 10 | 2 | 9 | 11 | 1 | 1 | 1 | 3 |
| Earnings Per Share (₹) | 0.04 | 1.56 | 0.05 | 0.84 | 10.41 | 1.17 | 0.97 | 14.10 | 8.01 | -40.49 | 13.29 | 15.49 | 12.71 | 14.15 | 8.21 | 12.05 | 8.36 | 10.71 | 12.18 | 10.12 | 1.46 | 8.70 | 10.95 | 1.14 | 2.26 | 3.39 | 2.47 |
Related Pages for Balaxi Pharmaceuticals
Additional stock information and data for BALAXI
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Total Assets | 310 | 258 | 240 | 177 | 100 | 36 | 6 |
| Current Assets | 243 | 210 | 194 | 141 | 94 | 35 | 6 |
| Fixed Assets | 41 | 41 | 41 | 29 | 2 | 0 | 0 |
| Capital Work in Progress | 22 | 2 | 3 | 1 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 3 | 0 | 0 |
| Other Assets | 247 | 215 | 195 | 147 | 94 | 36 | 6 |
| LIABILITIES | |||||||
| Total Liabilities | 310 | 258 | 240 | 177 | 100 | 36 | 6 |
| Current Liabilities | 24 | 3 | 4 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | |||||||
| SHAREHOLDERS' EQUITY | |||||||
| Total Equity | 232 | 201 | 183 | 113 | 65 | 28 | 4 |
| Share Capital | 11 | 11 | 10 | 10 | 10 | 10 | 3 |
| Reserves & Surplus | 221 | 187 | 162 | 103 | 55 | 18 | 1 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | -35 | 5 | 6 | 34 | 0 | -14 | -2 |
| Investing Activities | -22 | -1 | -11 | -29 | -6 | 0 | 0 |
| Financing Activities | 34 | 30 | 26 | 0 | 4 | 18 | 0 |
| Net Cash Flow | -23 | 34 | 21 | 6 | -2 | 4 | -2 |